Addressing the Challenges in Downstream Processing Today and Tomorrow - Newer classes of biotherapies will require innovations in processing technology. - BioPharm International

ADVERTISEMENT

Addressing the Challenges in Downstream Processing Today and Tomorrow
Newer classes of biotherapies will require innovations in processing technology.


BioPharm International Supplements
Volume 24, Issue 4, pp. s8-s15

REFERENCES

1. C. Scott, Bioprocess Intl. 7 (10, Suppl.), (2009).

2. G. Walsh, Eur. J. Pharm. Biopharm. 55 (1), 3–10 (2003).

3. X. Wang et. al., mAbs. 1 (3), 254-267 (2009).

4. G. Jagschies et. al., BioPharm. Int. 19 (June Suppl.), 10–19 (2006).

5. J. R. Birch and A. J. Racher. Adv. Drug Deliv. Rev. 58 (5–6), 671-685 (2006).

6. B.D. Kelley, mAbs 1 (5), 1–10 (2009).

7. B.D. Kelley et.al., Biotechnol. Bioeng, 101 (3), 553–566 (2008).

8. J.L. Coffman, J.F. Kramarczyk, and B.D. Kelley, Biotechnol. Bioeng. 100 (4), 605–618 (2008).

9. B.D. Kelley et. al., Biotechnol. Bioeng. 100 (5), 950–963 (2008).

10. J. Glynn et. al., BioPharm. Int. 22 (October Suppl.), 15-19 (2009).

11. E.J. Suda, et. al., J. Chromatogr. A. 1216 (27), 5256–5264 (2009).

12. B. Kelley, Biotechnol. Prog. 23 (5), 995–1008 (2007).

13. G.R. Bolton, J. Basha, and D.P. LaCasse, Biotechnol. Prog. 26 (6), 1671–1677.

14. C. Winter, US patent 0237762 (2007).

15. G.R. Bolton, H. Araya, and A.W. Boesch, "Membrane Evaporation for Generating Highly Concentrated Protein Therapeutics" International Patent Application WO 2010/111378 A1.

16. M. Shamashkin et. al., Recovery of Biological Products XIV, (Lake Tahoe, CA 2010)

17. A.L. Nelson, E. Dhimolea, and J.M. Reichert, Nat. Rev. Drug. Discov. 9, 767–74 (2010).

18. G. Walsh, Nat. Biotechnol. 29 (9), 917–924 (2010).

19. C. Sheridan, Nat. Biotechnol. 28 (4), 307-310 (2010).

20. G. Walsh, BioPharma. Int. 23 (10), 1–8 (2009).

21. A.L. Nelson and J.M. Reichert, Nat. Biotechnol. 27 (4), 331–337 (2009).

22. M.D. Zolodz et. al., J. Chromatogr. A. 1217 (2), 225–234 (2010).

23. B.N. Violand. "Initial purification of inclusion bodies," in Protein Purification Applications, S. Roe, Ed. (Oxford University Press, Oxford, UK, 2nd ed. 2001), pp. 19–27.

24. J.J. Buckley, S.D. Hoeltzli, and G.V. Johnson, Biotechnol. Appl. Biochem. 56 (1), 27–34 (2010).

25. V. Dechavanne et. al., Protein Expr. Purif. 75 (2), 192–203 (2011).

26. S.C. Alley, N.M. Okeley, and P.D. Senter, Curr. Opin. Chem. Biol. 14 (4), 529–537 (2010).

27. C.F. McDonagh et. al., Protein Eng. Des. Sel. 19 (7), 299–307 (2006).

28. J.R. Junutula et. al., Nat. Biotech. 26 (8), 92–-932 (2009).


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Novartis Sells Influenza Vaccine Business to CSL for $275 Million
October 27, 2014
Author Guidelines
Source: BioPharm International Supplements,
Click here